Polylacticcoglycolic acid – PLGA

Abstract Inflammatory bowel disease (IBD) is a complex chronic inflammatory disorder of the gastrointestinal (GI) tract with an uncertain etiology....

Abstract Over the last decade, scientists have shifted their focus to the development of smart carriers for the delivery of...

Abstract Resins are complex mixtures of natural constituents containing non-volatile and volatile terpenes, in combination with gums and polyphenols, used...

Abstract The hot-melt extrusion process is currently considered a prominent manufacturing technique in the pharmaceutical industry. The present study is...

Abstract Herein, a new type of controlled-release system is fabricated using polycaprolactone (PCL) and poly(lactic-co-glycolic acid) (PLGA) nanoparticles for the...

Abstract Inflammatory bowel disease (IBD) affects over 7 million people worldwide and significant side effects are associated with current therapies...

Abstract In situ forming implants are appealing long-acting dosage forms for both preclinical and clinical applications due to their simple manufacturing...

For successful treatment of diseases, sufficient therapeutics must be provided to the body. Microneedle applications in therapeutic delivery and analytics...

Oral Topiramate therapy is associated with systemic adverse effects including paresthesia,abdominal pain, and fluctuations in plasma levels. The purpose of...

Abstract Microarray patches (MAPs) offer a noninvasive and patient-friendly drug delivery method, suitable for self-administration, which is especially promising for...